Clinical Trials in Maryland

Showing 8961-8980 of 17,687 trials

Effects and Safety of OPK-88004 Doses in Men With Signs and Symptoms of Benign Prostatic Hyperplasia (BPH)

NCT03297398

This study will evaluate the safety and effectiveness of different doses of OPK-88004 compared to placebo on serum PSA compared to placebo in men with benign prostatic hyperplasia (BPH).

Benign Prostatic Hyperplasia

OPKO Health, Inc.114 participantsStarted Feb 2018

Anniston, Alabama, United States • Lincoln, California, United States • Sacramento, California, United States +12 more locations

COMPLETEDPhase 2/313 miles

An Integrated Assessment of the Safety and Effectiveness of Bexagliflozin for the Management of Essential Hypertension

NCT03514641

This integrated assessment consists of two studies, 603A and 603B, to be carried out sequentially in a common study population. Participating subjects informed of the trial design and their consent to participate in both studies were to be obtained in a single consent form. Approximately 680 male or female adult subjects were to be enrolled.

Essential Hypertension

Theracos673 participantsStarted Oct 2017

Birmingham, Alabama, United States • Birmingham, Alabama, United States • Birmingham, Alabama, United States +84 more locations

Effects and Safety of OPK-88004 Doses in Men With Signs and Symptoms of Benign Prostatic Hyperplasia (BPH)

An Integrated Assessment of the Safety and Effectiveness of Bexagliflozin for the Management of Essential Hypertension

Find Trials by Condition in Maryland

Phase 2B Efficacy/Safety of Ornithine Phenylacetate in Hospitalized Cirrhotic Patients With Hepatic Encephalopathy (STOP-HE)

T-cells Expressing an Anti-SLAMF7 CAR for Treating Multiple Myeloma

A Comparison of PRP Treatment to the IA vs. IA and EA Environments in Patients Diagnosed With Hip Osteoarthritis

A Study Evaluating Pertuzumab (Perjeta) Combined With Trastuzumab (Herceptin) and Standard Anthracycline-based Chemotherapy in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Locally Advanced, Inflammatory, or Early-stage Breast Cancer

Using Spices and Herbs to Increase Vegetable Intake Among Urban High School Students

Oxygen for Vascular Incisional Healing

Study to Investigate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years and Over With Moderate to Severe Atopic Dermatitis With the Option of Rescue Treatment in Flaring Subjects

A Study of the Effects of GC4419 on Radiation Induced Oral Mucositis in Patients With Head/Neck Cancer

Stress Management for Cancer Patients: How Well Does it Work? (C2H-D)

Safety and Efficacy Study of EXC 001 to Improve the Appearance of Scars From Prior Breast Surgery

A Phase 1/2, Open-label, Dose Finding Study to Evaluate CC-122 in Combination With Ibrutinib and Obinutuzumab in Subjects With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

First in Human Study for Safety and Tolerability of AL003.

A Study of MPT-0118 in Subjects With Advanced or Metastatic Refractory Solid Tumors

OptiMesh® for Lumbar Interbody Fusion Trial (OLIF)

Study of Nolasiban to Increase Pregnancy Rates in Women Undergoing IVF

A Study of Galunisertib (LY2157299) in Combination With Nivolumab in Advanced Refractory Solid Tumors and in Recurrent or Refractory NSCLC, or Hepatocellular Carcinoma

A Comparative Study of BAT1706 and EU Avastin® in Patients With Advanced Non Squamous Non Small Cell Lung Cancer

Registry to Improve the Adoption of Consensus Treatment Guidelines (IMPROVE Brady)